Natalie Sacks

2.6k total citations
22 papers, 2.0k citations indexed

About

Natalie Sacks is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Natalie Sacks has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Natalie Sacks's work include Immunotherapy and Immune Responses (15 papers), Prostate Cancer Treatment and Research (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Natalie Sacks is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Prostate Cancer Treatment and Research (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Natalie Sacks collaborates with scholars based in United States, Netherlands and Italy. Natalie Sacks's co-authors include Martin B. Keller, David B. Herzog, Philip W. Lavori, Jonathan W. Simons, Kristen Hege, Christine J. Yeh, Eric J. Small, Phillip W. Lavori, Walter J. Urba and Tanja D. de Gruijl and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Natalie Sacks

22 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalie Sacks United States 16 930 921 691 363 312 22 2.0k
Tara Berman United States 8 359 0.4× 465 0.5× 538 0.8× 79 0.2× 355 1.1× 21 1.7k
Joanna M. Watson United States 19 578 0.6× 443 0.5× 159 0.2× 42 0.1× 460 1.5× 37 1.9k
Lana Harder Germany 32 432 0.5× 835 0.9× 62 0.1× 171 0.5× 656 2.1× 73 2.5k
Agustín Lage Cuba 22 635 0.7× 874 0.9× 45 0.1× 347 1.0× 432 1.4× 65 1.9k
Karen Wright United States 23 82 0.1× 598 0.6× 64 0.1× 449 1.2× 500 1.6× 69 1.9k
Catharina M.P. Vos Netherlands 13 241 0.3× 280 0.3× 85 0.1× 54 0.1× 306 1.0× 15 1.6k
Michele C. Hayward United States 17 87 0.1× 399 0.4× 262 0.4× 347 1.0× 690 2.2× 45 1.7k
Michael Bishop United States 19 378 0.4× 463 0.5× 76 0.1× 44 0.1× 173 0.6× 43 1.2k
Alison D. Sheridan United States 11 456 0.5× 189 0.2× 173 0.3× 112 0.3× 96 0.3× 22 960
Leonard Horwitz United States 19 71 0.1× 410 0.4× 687 1.0× 130 0.4× 83 0.3× 60 1.6k

Countries citing papers authored by Natalie Sacks

Since Specialization
Citations

This map shows the geographic impact of Natalie Sacks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Sacks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Sacks more than expected).

Fields of papers citing papers by Natalie Sacks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Sacks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Sacks. The network helps show where Natalie Sacks may publish in the future.

Co-authorship network of co-authors of Natalie Sacks

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Sacks. A scholar is included among the top collaborators of Natalie Sacks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Sacks. Natalie Sacks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santegoets, Saskia J., Anita G.M. Stam, Sinéad M. Lougheed, et al.. (2014). Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab. Journal for ImmunoTherapy of Cancer. 2(1). 31–31. 91 indexed citations
2.
3.
Santegoets, Saskia J., Anita G.M. Stam, Sinéad M. Lougheed, et al.. (2012). T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment. Cancer Immunology Immunotherapy. 62(2). 245–256. 78 indexed citations
4.
Eertwegh, Alfons J. van den, Tanja D. de Gruijl, Saskia J. Santegoets, et al.. (2012). Lymphoid and myeloid biomarkers for clinical outcome of combined immunotherapy with granulocyte-macrophage colony-stimulating factor-tranduced allogeneic prostate cancer cells (GVAX) and ipilimumab in castration-resistant prostate cancer patients.. Journal of Clinical Oncology. 30(15_suppl). 2562–2562. 1 indexed citations
5.
6.
Higano, Celestia S., John M. Corman, David C. Smith, et al.. (2008). Phase 1/2 dose‐escalation study of a GM‐CSF‐secreting, allogeneic, cellular immunotherapy for metastatic hormone‐refractory prostate cancer. Cancer. 113(5). 975–984. 163 indexed citations
7.
Small, Eric J., Natalie Sacks, John Nemunaitis, et al.. (2007). Granulocyte Macrophage Colony-Stimulating Factor–Secreting Allogeneic Cellular Immunotherapy for Hormone-Refractory Prostate Cancer. Clinical Cancer Research. 13(13). 3883–3891. 183 indexed citations
8.
Simons, Jonathan W. & Natalie Sacks. (2006). Granulocyte-macrophage colony-stimulating factor−transduced allogeneic cancer cellular immunotherapy: The GVAX® vaccine for prostate cancer. Urologic Oncology Seminars and Original Investigations. 24(5). 419–424. 122 indexed citations
9.
Hoos, Axel, Giorgio Parmiani, Kristen Hege, et al.. (2006). A Clinical Development Paradigm for Cancer Vaccines and Related Biologics. Journal of Immunotherapy. 30(1). 1–15. 197 indexed citations
10.
Corman, John M., Eric J. Small, David P. Smith, et al.. (2006). 976: Immunotherapy with GVAX® Vaccine for Prostate Cancer Improves Predicted Survival in Metastatic Hormone Refractory Prostate Cancer: Results from Two Phase 2 Studies. The Journal of Urology. 175(4S). 315–315. 3 indexed citations
11.
12.
Simons, Jonathan W., Celestia S. Higano, Donald C. Smith, et al.. (2005). Clinical and immunologic findings in a phase 2 study of a GM-CSF-secreting prostate cancer cell line vaccine in patients with metastatic hormone-refractory prostate cancer (met HPRC). Journal of Clinical Oncology. 23(16_suppl). 2517–2517. 16 indexed citations
13.
Small, Eric J., Celestia S. Higano, Donald C. Smith, et al.. (2004). A phase 2 study of an allogeneic GM-CSF gene-transduced prostate cancer cell line vaccine in patients with metastatic hormone-refractory prostate cancer (HRPC). Journal of Clinical Oncology. 22(14_suppl). 4565–4565. 28 indexed citations
14.
Small, Eric J., Celestia S. Higano, David C. Smith, Natalie Sacks, & Jonathan W. Simons. (2004). A Phase 2 Study of an Allogeneic GM-CSF Gene-Transduced Prostate Cancer Cell Line Vaccine in Patients with Metastatic Hormone-Refractory Prostate Cancer. Journal of Immunotherapy. 27(6). S32–S32. 5 indexed citations
15.
Small, Eric J., Celestia S. Higano, Donald C. Smith, et al.. (2004). A phase 2 study of an allogeneic GM-CSF gene-transduced prostate cancer cell line vaccine in patients with metastatic hormone-refractory prostate cancer (HRPC). Journal of Clinical Oncology. 22(14_suppl). 4565–4565. 9 indexed citations
16.
Copeland, Paul M., Natalie Sacks, & David B. Herzog. (1995). Longitudinal Follow-Up of Amenorrhea in Eating Disorders. Psychosomatic Medicine. 57(2). 121–126. 38 indexed citations
17.
Beardslee, William R., et al.. (1993). The Impact of Parental Affective Disorder on Depression in Offspring: A Longitudinal Follow-up in a Nonreferred Sample. Journal of the American Academy of Child & Adolescent Psychiatry. 32(4). 723–730. 147 indexed citations
18.
Herzog, David B., Martin B. Keller, Natalie Sacks, Christine J. Yeh, & Philip W. Lavori. (1992). Psychiatric Comorbidity in Treatment-Seeking Anorexics and Bulimics. Journal of the American Academy of Child & Adolescent Psychiatry. 31(5). 810–818. 253 indexed citations
19.
Herzog, David B., et al.. (1992). The prevalence of personality disorders in 210 women with eating disorders.. PubMed. 53(5). 147–52. 133 indexed citations
20.
Herzog, David B., Martin B. Keller, Phillip W. Lavori, & Natalie Sacks. (1991). The course and outcome of bulimia nervosa.. PubMed. 52 Suppl. 4–8. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tara Berman Breakdown of academic impact, for papers by Joanna M. Watson Breakdown of academic impact, for papers by Lana Harder Breakdown of academic impact, for papers by Agustín Lage Breakdown of academic impact, for papers by Karen Wright Breakdown of academic impact, for papers by Catharina M.P. Vos Breakdown of academic impact, for papers by Michele C. Hayward Breakdown of academic impact, for papers by Michael Bishop Breakdown of academic impact, for papers by Alison D. Sheridan Breakdown of academic impact, for papers by Leonard Horwitz
Rankless by CCL
2026